Diluted EPS came in at $-0.08.
Filings will appear here once submitted to SEC EDGAR.
Common questions about OKYO Pharma's Q4 2024 earnings report.
OKYO Pharma (OKYO) reported Q4 2024 earnings on January 29, 2025 before market open.
OKYO Pharma reported diluted EPS of $-0.08 for Q4 2024.